Summary
Quest Diagnostics (DGX) filed an 8-K on July 22, 2021, primarily to announce its financial results for the second quarter ended June 30, 2021. The company issued a press release detailing these results, which has been furnished as an exhibit to the filing. Investors should review the press release for specific financial performance metrics, including revenue, earnings, and any commentary on business trends or outlook provided by management for the period.
Key Highlights
- 1Quest Diagnostics (DGX) released its Q2 2021 financial results on July 22, 2021, via an 8-K filing.
- 2The core purpose of the 8-K filing was to furnish a press release detailing the company's performance for the quarter ended June 30, 2021.
- 3Investors can find detailed financial performance information within the attached press release (Exhibit 99.1).
- 4The filing incorporates the press release by reference, making it an integral part of the report.
- 5No other significant operational or financial events were disclosed in this specific 8-K filing, beyond the routine quarterly earnings announcement.
Frequently Asked Questions
The main purpose of this 8-K filing is to officially announce and provide Quest Diagnostics' financial results for the second quarter ended June 30, 2021, through a furnished press release.
The detailed financial results are contained within the press release issued by Quest Diagnostics on July 22, 2021, which is attached as Exhibit 99.1 to this 8-K filing and incorporated by reference.
This 8-K filing itself primarily serves to report past financial results. Any forward-looking statements, guidance, or outlook would be detailed within the press release (Exhibit 99.1) that accompanies this filing. Investors should refer to that document for such information.